PremiumCompany AnnouncementsChimeric Therapeutics Secures $6.6 Million to Boost Clinical Trials Chimeric Therapeutics Initiates Trading Halt for Capital Raising Announcement Chimeric Therapeutics Reports Promising Results in ADVENT-AML Trial PremiumCompany AnnouncementsChimeric Therapeutics Issues New Securities to Bolster R&D Chimeric Therapeutics Expands CHM CDH17 Clinical Trial to Emory Winship Cancer Institute Chimeric Therapeutics Completes $1 Million Entitlement Offer to Advance Cancer Therapies PremiumCompany AnnouncementsChimeric Therapeutics Announces New ASX Quotation for Options Chimeric Therapeutics Launches $3.2 Million Entitlement Offer Chimeric Therapeutics Announces Proposed Issue of 25 Million Securities